1. Targeting the NRF-2/RHOA/ROCK signaling pathway with a novel aziridonin, YD0514, to suppress breast cancer progression and lung metastasis
   Dengfeng Li et al, 2018, Cancer Letters CrossRef
2. Synergistic anticancer effects of formononetin and temozolomide on glioma C6 cells
   Xiong Zhang et al, 2018, Biological & Pharmaceutical Bulletin CrossRef
3. Zirconium-Porphyrin PCN-222: pH-responsive Controlled Anticancer Drug Oridonin
   Xin Leng et al, 2018, Evidence-Based Complementary and Alternative Medicine CrossRef
4. ROS/JNK/c-Jun axis is involved in oridonin-induced caspase-dependent apoptosis in human colorectal cancer cells
   Di Zhang et al, 2019, Biochemical and Biophysical Research Communications CrossRef
5. Oridonin synergistically enhances the anti-tumor efficacy of doxorubicin against aggressive breast cancer via pro-apoptotic and anti-angiogenic effects
   Jingjing Li et al, 2019, Pharmacological Research CrossRef
6. Upregulation of MDR- and EMT-Related Molecules in Cisplatin-Resistant Human Oral Squamous Cell Carcinoma Cell Lines
   Hyeong Sim Choi et al, 2019, IJMS CrossRef
7. Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
   Weixiao An et al, 2019, Front. Pharmacol. CrossRef
8. Oridonin elevates sensitivity of ovarian carcinoma cells to cisplatin via suppressing cisplatin-mediated autophagy
   Yaxian Zhao et al, 2019, Life Sciences CrossRef
9. null
   Jose J.G. Marin et al, 2020 CrossRef
10. Oridonin Suppresses Human Gastric Cancer Growth in Vitro and in Vivo via Inhibition of VEGF, Integrin β3, and PCNA
    Qiong Yang et al, 2020, Biological & Pharmaceutical Bulletin CrossRef
11. Oridonin inhibits VEGF-A-associated angiogenesis and epithelial-mesenchymal transition of breast cancer in vitro and in vivo.
    Chunyu Li et al, 2018, Oncol Lett CrossRef
12. Sophocarpine can enhance the inhibiting effect of oxaliplatin on colon cancer liver metastasis—in vitro and in vivo
    Yu-Shen Yang et al, 2021, Naunyn-Schmiedeberg's Arch Pharmacol CrossRef
13. Comprehensive characterization of a drug-resistance-related ceRNA network across 15 anti-cancer drug categories
    Bing Liu et al, 2021, Molecular Therapy - Nucleic Acids CrossRef
14. Berberine Reverses Breast Cancer Multidrug Resistance Based on Fluorescence Pharmacokinetics In Vitro and In Vivo
    Ke Qian et al, 2021, ACS Omega CrossRef
15. Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles
    Xinglong Fan et al, 2021, Biomedicine & Pharmacotherapy CrossRef
16. Oridonin: A Review of Its Pharmacology, Pharmacokinetics and Toxicity.
    Xiang Li et al, 2021, Front Pharmacol CrossRef
17. Recent progress of oridonin and its derivatives for cancer therapy and drug resistance
    Yong-Feng Guan et al, 2021, Med Chem Res CrossRef
18. Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells
    Liliya Kazantseva et al, 2021, Pharmacol. Rep CrossRef
19. Celastrol Inhibits the Proliferation and Decreases Drug Resistance of Cisplatin- Resistant Gastric Cancer SGC7901/DDP Cells
    Dongmei Zhan et al, 2022, ACAMC CrossRef
20. Improving cancer immunotherapy via co-delivering checkpoint blockade and thrombospondin-1 downregulator
    Qingqing Xiao et al, 2022, Acta Pharmaceutica Sinica B CrossRef
21. Recent advances in oridonin derivatives with anticancer activity
    Pedro J. M. Sobral et al, 2023, Front. Chem. CrossRef
22. Direct cellular targets and anticancer mechanisms of the natural product oridonin
    Jialin Yao et al, 2023, MedComm – Future Medicine CrossRef
23. Oridonin and its derivatives for cancer treatment and overcoming therapeutic resistance
    Xi Liu et al, 2021, Genes & Diseases CrossRef
24. Enhanced lysosomal escape of cell penetrating peptide-functionalized metal-organic frameworks for co-delivery of survivin siRNA and oridonin
    Mengru Cai et al, 2023, Journal of Colloid and Interface Science CrossRef
25. Oridonin Promotes Apoptosis in Rheumatoid Arthritis Fibroblast-like Synoviocytes Through PERK/eIF2α/CHOP of Endoplasmic Reticulum Stress Pathway
    Shoudi He et al, 2023, DNA and Cell Biology CrossRef
26. The ‘speck’-tacular oversight of the NLRP3-pyroptosis pathway on gastrointestinal inflammatory diseases and tumorigenesis
    Valentina Arrè et al, 2023, J Biomed Sci CrossRef
27. Phytochemicals: Current strategy to sensitize cancer cells to cisplatin.
    Chao-Yue Sun et al, 2019, Biomed Pharmacother CrossRef
28. Highly anticipated natural diterpenoids as an important source of new drugs in 2013–2023
    Yingjie Wang et al, 2024, Chinese Chemical Letters CrossRef
29. Natural Products Reverse Cisplatin Resistance in the Hypoxic Tumor Microenvironment
    Chuansheng Yang et al, 2024, Cancer Letters CrossRef
30. Rabdosia rubescens (Hemsl.) H. Hara: A Potent Anti-Tumor Herbal Remedy - Botany, Phytochemistry, and Clinical Breakthroughs
    Shiyong Gao et al, 2024, Journal of Ethnopharmacology CrossRef